mhurhangee/ep-ind-claims huggingface dataset:
An imaging apparatus comprising: an imaging optical system that obtains an optical image of a photographic subject; a plurality formed by three or more image sensor elements that output image data based on the optical image of the photographic subject obtained by the imaging optical system; an electric power supply controller that controls electric power supply to the plurality of image sensor elements; and a distance metering device that includes the plurality of image sensor elements and the electric power supply controller, and measures a distance to the photographic subject based on an output of the image sensor elements, wherein the plurality of image sensor elements are aligned in line and formed on one semiconductor wafer, characterized in that at least one of the plurality of image sensor elements for distance measurement is configured for a different use and the electric power supply controller performs either electric power supply to the image sensor elements for distance measurement or to the at least one of said plurality of image sensor elements for the different use in accordance with operating conditions set to the imaging apparatus. an imaging optical system that obtains an optical image of a photographic subject; a plurality formed by three or more image sensor elements that output image data based on the optical image of the photographic subject obtained by the imaging optical system; an electric power supply controller that controls electric power supply to the plurality of image sensor elements; and a plurality formed by three or more image sensor elements that output image data based on the optical image of the photographic subject obtained by the imaging optical system; an electric power supply controller that controls electric power supply to the plurality of image sensor elements; and a distance metering device that includes the plurality of image sensor elements and the electric power supply controller, and measures a distance to the photographic subject based on an output of the image sensor elements, wherein the plurality of image sensor elements are aligned in line and formed on one semiconductor wafer, characterized in that at least one of the plurality of image sensor elements for distance measurement is configured for a different use and the electric power supply controller performs either electric power supply to the image sensor elements for distance measurement or to the at least one of said plurality of image sensor elements for the different use in accordance with operating conditions set to the imaging apparatus. wherein the plurality of image sensor elements are aligned in line and formed on one semiconductor wafer, characterized in that at least one of the plurality of image sensor elements for distance measurement is configured for a different use and the electric power supply controller performs either electric power supply to the image sensor elements for distance measurement or to the at least one of said plurality of image sensor elements for the different use in accordance with operating conditions set to the imaging apparatus.
A method of preparing a compound of Formula II, or a salt thereof, from a compound of Formula I, wherein in Formula II R' represents a linear, branched and/or cyclic alkyl group having 1 to 10 carbon atoms, and R" represents a linear, branched and/or cyclic alkyl group having 1 to 10 carbon atoms, comprising: (i) replacing the group R in the compound of Formula I, wherein R is H or methyl, by a group R' being a linear, branched and/or cyclic alkyl group having 1 to 10 carbon atoms; (ii) addition of methyl vinyl ketone to obtain 1-[(5α,7α)-17-alkyl-4,5-epoxy-3-hydroxy-6-methoxy-6,14-ethenomorphinan-7-yl]ethanone or 1-[(5α,7α)-17-alkyl-4,5-epoxy-3-alkoxy-6-methoxy-6,14-ethenomorphinan-7-yl]ethanone; (iii-a) converting the acetyl group in position 7 into a tertiary alkyl alcohol having a general structure -C- -(CH 3)-R", wherein R" represents a linear, branched and/or cyclic alkyl group with 1 to 10 carbon atoms; and (iv-a) reducing the etheno group in position 18,19 to form the compound of Formula II; and (v) optionally converting the product from step (iv-a) into an addition salt, preferably a pharmaceutically acceptable salt, wherein introducing and later releasing protecting groups is avoided; and wherein R'" is H, wherein step (iv-a) is carried out after step (iii-a), wherein step (iii-a) is carried out using essentially tert-butylmethylether, 2-methyl-tetrahydrofuran, dimethoxymethane or mixtures thereof as solvent, wherein other solvents can be contained in a solvent mixture with less than 10 wt.%, based on the total weight of all solvents used in step (iii-a). (i) replacing the group R in the compound of Formula I, wherein R is H or methyl, by a group R' being a linear, branched and/or cyclic alkyl group having 1 to 10 carbon atoms; (ii) addition of methyl vinyl ketone to obtain 1-[(5α,7α)-17-alkyl-4,5-epoxy-3-hydroxy-6-methoxy-6,14-ethenomorphinan-7-yl]ethanone or 1-[(5α,7α)-17-alkyl-4,5-epoxy-3-alkoxy-6-methoxy-6,14-ethenomorphinan-7-yl]ethanone; (iii-a) converting the acetyl group in position 7 into a tertiary alkyl alcohol having a general structure -C- -(CH 3)-R", wherein R" represents a linear, branched and/or cyclic alkyl group with 1 to 10 carbon atoms; and (iv-a) reducing the etheno group in position 18,19 to form the compound of Formula II; and (iii-a) converting the acetyl group in position 7 into a tertiary alkyl alcohol having a general structure -C- -(CH 3)-R", wherein R" represents a linear, branched and/or cyclic alkyl group with 1 to 10 carbon atoms; and (iv-a) reducing the etheno group in position 18,19 to form the compound of Formula II; and (v) optionally converting the product from step (iv-a) into an addition salt, preferably a pharmaceutically acceptable salt, wherein introducing and later releasing protecting groups is avoided; and
A transdermal composition comprising a phosphatidylcholine derived from a natural product, L-carnitine, a polyalcohol, and water, wherein the phosphatidylcholine is at least one selected from the group consisting of egg yolk phosphatidylcholine and soybean phosphatidylcholine, and wherein the polyalcohol is a mixture of propylene glycol and glycerin, and the transdermal composition does not comprise lipophilic base.
A method for controlling a density centrifuge blood processing system for separating fluid components, said method comprising the steps of: performing a first measurement of an operating condition of a blood processing device corresponding to a first time; performing a second measurement of said operating condition of said blood processing device corresponding to a second time; analyzing said first and second measurements of said operating condition using a predictive data analysis algorithm, wherein operation of said predictive data analysis algorithm generates a predicted operating condition of said blood processing device corresponding to a selected future time; comparing the predicted operating condition of said blood processing device corresponding to the selected future time to a desired operating condition; and automatically adjusting at least one setting of said blood processing device based on said comparison of the predicted operating condition of said blood processing device at said future time and the desired operating condition, thereby controlling said blood processing device. performing a first measurement of an operating condition of a blood processing device corresponding to a first time; performing a second measurement of said operating condition of said blood processing device corresponding to a second time; analyzing said first and second measurements of said operating condition using a predictive data analysis algorithm, wherein operation of said predictive data analysis algorithm generates a predicted operating condition of said blood processing device corresponding to a selected future time; comparing the predicted operating condition of said blood processing device corresponding to the selected future time to a desired operating condition; and automatically adjusting at least one setting of said blood processing device based on said comparison of the predicted operating condition of said blood processing device at said future time and the desired operating condition, thereby controlling said blood processing device.
An evaluation method of suitable silica powder for forming a bubble-free layer of a vitreous silica crucible for pulling of a silicon single crystal, comprising: a process of measuring a porosity between silica particles in the silica powder; a process of melting the silica powder; a process of measuring a bubble content rate of a vitreous silica block obtained by cooling to harden the melted silica powder; characterized by determining a contraction index based on the measured porosity between silica particles of the silica powder and the measured bubble content rate of the vitreous silica block; and determining whether the silica powder is suitable for forming a bubble-free layer of a vitreous silica crucible for pulling of a silicon single crystal based on the contraction index. a process of measuring a porosity between silica particles in the silica powder; a process of melting the silica powder; a process of measuring a bubble content rate of a vitreous silica block obtained by cooling to harden the melted silica powder; characterized by determining a contraction index based on the measured porosity between silica particles of the silica powder and the measured bubble content rate of the vitreous silica block; and determining whether the silica powder is suitable for forming a bubble-free layer of a vitreous silica crucible for pulling of a silicon single crystal based on the contraction index.
A combustion pressure sensor (1, 301, 401) comprising a tubular housing extending in an axial direction; a displacement member at least a portion of which is disposed within the housing and which is displaced in the axial direction with pressure received from a forward side in the axial direction; and a tubular connection member (160, 460) which elastically connects the displacement member to the housing, the combustion pressure sensor (1, 301, 401) having a housing weld (W1, W3) which is formed by energy-beam-welding the housing and the connection member (160, 460) annularly in a circumferential direction of the housing and the connection member (160, 460) while the housing and the connection member (160, 460) are separated from each other at least partially in the circumferential direction; which contains metal components melted from the housing and metal components melted from the connection member (160, 460); and which includes, in a longitudinal section of the combustion pressure sensor (1, 301, 401), a weld having a wedge-shape resulting from wedgewise melting of a portion of the housing, characterized in that at least a portion in the circumferential direction of the housing weld (W1, W3) is a bulge housing weld (RW1, RW3) which bulges, with respect to a first adjacent portion (176, 476), in a direction directed from a second adjacent portion toward the first adjacent portion (176, 476) along a radial direction, where the first adjacent portion (176, 476) is a portion of the connection member (160, 460) adjacent to the housing weld (W1, W3), and the second adjacent portion is a portion of the housing adjacent to the housing weld (W1, W3), wherein the housing weld welds the housing and a first end portion of the connection member wherein the first end portion is the very end of the connection member.
An seat assembly comprising: a base structure having a seat pan shell and a backrest shell; and one or more attachment structures which removably couple the seat pan shell and the backrest shell to a seat surface arrangement or a utility surface arrangement, wherein the seat surface arrangement and the utility surface arrangement are exchangeable and alternatingly attachable to the base structure; and wherein the base structure is convertible between a passenger seat and a utility element based on the coupling of the seat surface arrangement or the utility surface arrangement, respectively, to the base structure. a base structure having a seat pan shell and a backrest shell; and one or more attachment structures which removably couple the seat pan shell and the backrest shell to a seat surface arrangement or a utility surface arrangement, wherein the seat surface arrangement and the utility surface arrangement are exchangeable and alternatingly attachable to the base structure; and wherein the base structure is convertible between a passenger seat and a utility element based on the coupling of the seat surface arrangement or the utility surface arrangement, respectively, to the base structure.
Tamper-evident pharmaceutical packaging for a pre-filled syringe, comprising: - a rigid housing made of glass or plastic material, - the housing being shaped to receive at least one pre-filled syringe; - the housing forming at least one receiving chamber shaped to receive and physically protect a single pre-filled syringe; and having a tip section, a barrel section and a plunger section, respectively dimensioned to receive the tip, the barrel and the plunger of the pre-filled syringe; - the housing having an access opening to the plunger section of each of the at least one receiving chamber; - each access opening being arranged to be positioned remote from the tip section of the housing; - the packaging further comprising at least one openable cover, each cover hermetically sealing one of the at least one access openings of the housing; wherein - the cover is a foil which is tamper-evident; - the foil is puncture-proof; - the foil is provided on its internal side with a resistant layer of rigid material being a layer of a composition comprising an active agent, the active agent being any substance that is able to trap a gaseous substance, the active agent being preferably a desiccant and/or an oxygen scavenger. - a rigid housing made of glass or plastic material, - the housing being shaped to receive at least one pre-filled syringe; - the housing forming at least one receiving chamber shaped to receive and physically protect a single pre-filled syringe; and having a tip section, a barrel section and a plunger section, respectively dimensioned to receive the tip, the barrel and the plunger of the pre-filled syringe; - the housing having an access opening to the plunger section of each of the at least one receiving chamber; - each access opening being arranged to be positioned remote from the tip section of the housing; - the packaging further comprising at least one openable cover, each cover hermetically sealing one of the at least one access openings of the housing; wherein - the cover is a foil which is tamper-evident; - the foil is puncture-proof; - the foil is provided on its internal side with a resistant layer of rigid material being a layer of a composition comprising an active agent, the active agent being any substance that is able to trap a gaseous substance, the active agent being preferably a desiccant and/or an oxygen scavenger.
A process for producing a polycarbonate which comprises subjecting one or more dihydroxy compounds comprising a dihydroxy compound having at least one linking group -CH 2 -O- in the molecule thereof to melt polycondensation with a carbonic acid diester using at least two serially arranged reactors to produce a polycarbonate, characterized in that in the reactors, the difference between the temperature of a polymer and the temperature of a heating medium is regulated to 80°C or smaller when the polycarbonate yielded has a reduced viscosity of 0.10 dL/g or lower, or to 60°C or smaller when the polycarbonate yielded has a reduced viscosity exceeding 0.10 dL/g but not higher than 0.40 dL/g, or to 40°C or smaller when the polycarbonate yielded has a reduced viscosity exceeding 0.40 dL/g, the reduced viscosity determined as outlined in the experimental part of the description.
A preparation comprising an antigen of a pathogenic bacterial species for use in treating a cancer situated in the colon of a subject, wherein the preparation elicits an immune response in the subject, and wherein the pathogenic bacterial species is pathogenic in the colon of a healthy subject, and wherein the pathogenic bacterial species is Escherichia coli.
An apparatus for operation in a wireless communication system conforming to a wireless LAN standard, using data defined by the wireless LAN standard, the apparatus being configured to: set a first value selected from among a plurality of possible values for the apparatus to determine a role suitability of the apparatus, the first value being based on a plurality of specific functions of the apparatus; receive a second value from a further apparatus, the second value being selected from among a plurality of possible values for the further apparatus and representing a role suitability of the further apparatus, the second value being based on a plurality of specific functions of the further apparatus; compare the first value with the second value; and set, if the first value is larger than the second value, the apparatus to perform the role of an access point and thereby set the apparatus to transmit a beacon. set a first value selected from among a plurality of possible values for the apparatus to determine a role suitability of the apparatus, the first value being based on a plurality of specific functions of the apparatus; receive a second value from a further apparatus, the second value being selected from among a plurality of possible values for the further apparatus and representing a role suitability of the further apparatus, the second value being based on a plurality of specific functions of the further apparatus; compare the first value with the second value; and set, if the first value is larger than the second value, the apparatus to perform the role of an access point and thereby set the apparatus to transmit a beacon.
A warewashing detergent composition comprising: (a) a cleaning agent comprising a detersive amount of a surfactant; (b) an alkaline source in an amount effective to provide a use composition having a pH of at least about 8 when measured at a solids concentration of about 0.5 wt. %; and (c) a corrosion inhibitor in an amount sufficient for reducing corrosion of glass when the warewashing detergent composition is combined with water of dilution at a dilution ratio of dilution water to detergent composition of at least about 20:1, wherein the amount in the use composition is about 6 to about 300 ppm, the corrosion inhibitor comprising: (i) a source of aluminum ion; and (ii) a source of calcium ion, wherein the warewashing composition is provided in the form of a solid, a gel or a paste, and wherein the corrosion inhibitor comprises a calcium/aluminum corrosion inhibitor having a molar ratio of calcium ion to aluminum ion of less than about 1:4 or a molar ratio of calcium ion to aluminum ion of greater than about 2:1. (a) a cleaning agent comprising a detersive amount of a surfactant; (b) an alkaline source in an amount effective to provide a use composition having a pH of at least about 8 when measured at a solids concentration of about 0.5 wt. %; and (c) a corrosion inhibitor in an amount sufficient for reducing corrosion of glass when the warewashing detergent composition is combined with water of dilution at a dilution ratio of dilution water to detergent composition of at least about 20:1, wherein the amount in the use composition is about 6 to about 300 ppm, the corrosion inhibitor comprising: (i) a source of aluminum ion; and (ii) a source of calcium ion, wherein the warewashing composition is provided in the form of a solid, a gel or a paste, and wherein the corrosion inhibitor comprises a calcium/aluminum corrosion inhibitor having a molar ratio of calcium ion to aluminum ion of less than about 1:4 or a molar ratio of calcium ion to aluminum ion of greater than about 2:1. (i) a source of aluminum ion; and (ii) a source of calcium ion,
A fluid collection device, comprising: at least one wicking material including an outer surface; a fluid impermeable coating adhered to at least a portion of the outer surface of the at least one wicking material, the fluid impermeable coating defining a chamber within the fluid collection device partially enclosing the at least one wicking material and defining an opening through which a portion of the at least one wicking material is exposed, the opening configured to be positioned adjacent to a female urethra; wherein the fluid collection device is substantially cylindrical; wherein the at least one wicking material is disposed in a substantially cylindrical configuration; the fluid collection device further comprising a first endcap disposed over a first end of the cylindrical configuration and a second endcap disposed over a second end of the cylindrical configuration, wherein the first endcap and the second endcap retain the wicking material in the cylindrical configuration; and further wherein: the endcaps (232, 234) are sealed in the fluid impermeable coating along with the wicking material. at least one wicking material including an outer surface; a fluid impermeable coating adhered to at least a portion of the outer surface of the at least one wicking material, the fluid impermeable coating defining a chamber within the fluid collection device partially enclosing the at least one wicking material and defining an opening through which a portion of the at least one wicking material is exposed, the opening configured to be positioned adjacent to a female urethra; wherein the fluid collection device is substantially cylindrical; wherein the at least one wicking material is disposed in a substantially cylindrical configuration; the fluid collection device further comprising a first endcap disposed over a first end of the cylindrical configuration and a second endcap disposed over a second end of the cylindrical configuration, wherein the first endcap and the second endcap retain the wicking material in the cylindrical configuration; and further wherein: the endcaps (232, 234) are sealed in the fluid impermeable coating along with the wicking material.
A reduced-pressure source (140, 240, 340) for use with a reduced-pressure system to treat a tissue site on a patient, characterised by the reduced-pressure source (140, 240, 340) comprising: a pump housing (156, 256) forming a sealed space within the pump housing (156, 256) having a positive-pressure chamber and a reduced-pressure chamber (268, 244); and a vacuum pump disposed within the sealed space, the vacuum pump having a reduced-pressure outlet fluidly coupled to the reduced-pressure chamber (268, 244) and an exhaust outlet (272, 495) fluidly coupled to the positive-pressure chamber; the pump housing (156, 356) is formed in part by an enclosure member (158, 258, 358), where the enclosure member (158, 258) comprises a polymeric, porous, hydrophobic material for allowing the exhaust gas to exit the positive-pressure chamber through the enclosure member (158, 258, 358) without a vent opening. a pump housing (156, 256) forming a sealed space within the pump housing (156, 256) having a positive-pressure chamber and a reduced-pressure chamber (268, 244); and a vacuum pump disposed within the sealed space, the vacuum pump having a reduced-pressure outlet fluidly coupled to the reduced-pressure chamber (268, 244) and an exhaust outlet (272, 495) fluidly coupled to the positive-pressure chamber; the pump housing (156, 356) is formed in part by an enclosure member (158, 258, 358), where the enclosure member (158, 258) comprises a polymeric, porous, hydrophobic material for allowing the exhaust gas to exit the positive-pressure chamber through the enclosure member (158, 258, 358) without a vent opening.